355 Results (Page 14 of 15)
Phillipines Markets Research Reports
Philippines Genomic Diagnostics Market Analysis
Philippines Genomic Diagnostics Market was valued at $71.83 Mn in 2023 and is predicted to grow at a CAGR of 17% from 2023 to 2030, to $215.58 Mn by 2030. The key drivers of this industry include high prevalence of genetic disorders, technological advancements, and increased healthcare expenditure. The industry is primarily dominated by Illumina, 23andMe, Myriad Genetics, and Amgen among others.
Philippines Compression Therapy Market Analysis
Philippines Compression Therapy Market was valued at $8 Mn in 2022 and is estimated to reach $13 Mn in 2030, exhibiting a CAGR of 6.1% during the forecast period. The increasing occurrence of venous disorders such as leg ulcers, deep vein thrombosis, lymphedema, varicose veins, and blood clots is a major factor contributing to the expansion of the compression therapy market. Major participants in this sector include companies like Mölnlycke Health Care AB, Sigvaris, GC Medical Supply Co., Medi, Bauerfeind, Juzo, McKesson Corporation, Cardinal Health, BSN Medical, and Hartmann Group.
Philippines Mouth Ulcer Therapeutics Market Analysis
The Philippines Mouth Ulcer Therapeutics Market was valued at $3.3 Mn in 2023 and is projected to grow at a CAGR of 4.4% from 2023 to 2023, to $4.5 Mn by 2030. The key drivers of this industry are rising awareness about oral hygiene, increasing demand for rapid healing products, growing geriatric population, rise in tobacco consumption, increasing incidence of oral diseases, chemical-based toothpaste and unhealthy lifestyles etc. The industry is primarily dominated by players such as Bristol-Myers Squibb Company, Unilab, GlaxoSmithKline PLC, Pfizer, Inc. among others.
Philippines Bariatric Surgery Devices Market Analysis
The Philippines Bariatric Surgery Devices Market was valued at $5.8 Mn in 2023 and is projected to grow at a CAGR of 5.7% from 2023 to 2023, to $8.6 Mn by 2030. Major factors driving the market for bariatric surgical devices include the rising incidence of adult obesity brought on by altered lifestyle patterns and excessive calorie consumption. The demand for bariatric operations is also anticipated to rise over the forecast period due to increased government backing and growing public awareness of the market's unhealthy food and beverage offerings and how they affect BMI, thus driving the market growth of the Bariatric Surgery Devices. The prominent players in the market are Philips, Medline Industries, Medtronic, B. Braun, Asenus Surgical, Johnson & Johnson, Cousin Surgery among others.
Philippines CT Scan Market Analysis
Philippines CT Scan Market was valued at $10.14 Mn in 2023 and is predicted to grow at a CAGR of 8.37% from 2023 to 2030, to $17.80 Mn by 2030. The key drivers of this industry include the rising burden of chronic diseases, the growing population, and technological advancements. The industry is primarily dominated by GE HealthCare, Siemens Healthineers, Canon Medical Systems, and NeuroLogica Corp. among others.
Philippines Lipid Disorder Therapeutics Market Analysis
The Philippines Lipid Disorder Therapeutics Market was valued at $50.5 Mn in 2023 and is predicted to grow at a CAGR of 13.63% from 2023 to 2030, to $123.5 Mn by 2030. Philippines Lipid Disorder Therapeutics Market is growing due to the Rising Prevalence of Cardiovascular Diseases, Growing Awareness, Government Initiatives, and funding. The industry is primarily dominated by players such as Sanofi, Pfizer, Inc., GlaxoSmithKline plc, Novartis AG, Merck & Co., Inc., Amgen Inc., Takeda Pharmaceutical Company Limited, Sun Pharmaceutical Industries Ltd., AbbVie Inc., Viatris, AstraZeneca PLC, and Dr. Reddys Laboratories Ltd.
Philippines Mental Health Apps Market Analysis
The Philippines Mental Health Apps Market was valued at $13.64 Mn in 2023 and is predicted to grow at a CAGR of 15.7% from 2023 to 2030, to $37.86 Mn by 2030. The key drivers of this industry include increasing smartphone penetration, a shortage of professionals, and government support. The industry is primarily dominated by players such as Calm, Happify, Ten Percent Happier, and Lusog-Isip among others.
Philippines Bio-Implant Market Analysis
The Philippines Bio-implant Market was valued at $143 Mn in 2023 and is predicted to grow at a CAGR of 6.4% from 2023 to 2030, to 220.8 Mn by 2030. The Philippines Bio-implant Market is growing due to like the Aging Population, Growing Medical Tourism Industry, and Government Healthcare Initiatives. The market is primarily dominated by players such as Orthopaedic International, OrthoMed, Medline Philippines, Zimmer Biomet, Stryker Boston Scientific Corporation, Otto Bock Holding GmbH & Co. KG, and Medtronic plc.
Philippines Actinic Keratosis Therapeutic Market Analysis
According to estimates, the Philippines Actinic Keratosis Therapeutic Market is expected to reach around $23 Mn by 2030, up from $15 Mn in 2022, growing at a compound annual growth rate of 5.4% over the forecast period. The Philippines Actinic Keratosis Therapeutic Market is set to expand with enhanced treatment options, telemedicine advancements, government initiatives in remote healthcare, and a growing prevalence due to changing lifestyles and aging population, all contributing to heightened market demand. DUSA Pharmaceuticals, Novartis, Perrigo, LEO Pharma, Bausch Health, Taro Pharmaceutical etc are the key players in the Philippines Actinic Keratosis Therapeutic Market
Philippines Brain Cancer Therapeutics Market
Philippines Brain Cancer Therapeutics Market valued at $5 Mn in 2022, projected to reach $12 Mn by 2030 with a 11.1% CAGR. Anticipated increases in the occurrence of brain cancer, particularly glioblastoma multiforme, are expected to substantially boost the need for treatments targeting brain cancer, thereby impacting the market's overall landscape. Currently, prominent pharmaceutical entities in the market include Merck & Co, Amgen, Roche, Pfizer, Teva Pharmaceutical, Karyopharm Therapeutics, Novartis, AstraZeneca, Bristol Myers Squibb, and Eli Lilly.
Philippines Herbal Supplements Market Report
The Philippines Herbal Supplements Market was valued at $11.57 Mn in 2023 and is predicted to grow at a CAGR of 6.7% from 2023 to 2030, to $18.22 Mn by 2030. The key drivers of this industry include a growing middle-class population, rising awareness, and health consciousness. The industry is primarily dominated by players such as Himalaya Wellness, Herbalife, Dabur, and Amway among others.
Philippines Clinical Nutrition for Chronic Kidney Diseases Market Analysis
Philippines Clinical Nutrition for Chronic Kidney Diseases Market was valued at $3.50 Mn in 2023 and is predicted to grow at a CAGR of 6.53% from 2023 to 2030, to $5.40 Mn by 2030. The key drivers of this industry include the rising prevalence of CKD, increased awareness and education, and advancements in nutritional science. The industry is primarily dominated by Abbott Nutrition, Pfizer Inc., Bayer AG, and Nestlé Health Science among others.
Philippines Brugada Syndrome Market Analysis
The Philippines Brugada Syndrome Market was valued at $2.6 Mn in 2023 and is predicted to grow at a CAGR of 8.3% from 2023 to 2030, to $4.6 Mn by 2030. The key drivers of the market include growing prevalence of cardiovascular diseases, geriatric population, and advancements in genetic testing. The prominent players of the Philippines Brugada Syndrome Market are Ajanta, Pascual Laboratories, Bauch Laboratories, Uni-Pharma Phils, Roche, and Medtronic, among others.
Philippines Dental Endodontics Market Analysis
Philippines Dental Endodontics Market was valued at $3.90 Mn in 2023 and is predicted to grow at a CAGR of 4.8% from 2023 to 2030, to $5.30 Mn by 2030. The key drivers of this industry include growing demand for cosmetic dentistry, increasing disposable income, rising prevalence of dental problems, and growing dental awareness. The industry is primarily dominated by Coltene, Dentsply Sirona, FKG Dentaire, and Ultradent Products among others.
Philippines Clinical Nutrition Market Analysis
The Philippines Clinical Nutrition Market was valued at $67.5 Mn in 2023 and is projected to grow at a CAGR of 5.84% from 2023 to 2023, to $100.4 Mn by 2030. The key drivers of this industry are increasing prevalence of chronic diseases and metabolic disorders, aging population, increasing awareness of the importance of nutrition for health, product innovations and technological advancements, government initiatives and rising healthcare expenditure, rising incidence of malnutrition especially in paediatric patients which has contributed to market growth. The industry is primarily dominated by players such as Vitacare, BioEssence, United Laboratories, USANA Health Sciences, Mead Johnson & Company, LLC among others.
Philippines Breast Pump Market Report
The Philippines Breast Pump Market was valued at $6.5 Mn in 2023 and is predicted to grow at a CAGR of 9.1% from 2023 to 2030, to $11.9 Mn by 2030. The key drivers of the market include rising employment rate of women, increasing healthcare expenditure, and growing consumer awareness. The prominent players of the Philippines Breast Pump Market are Asia Connection, Philips Avent, Advin Healthcare, Ardo Medical AG, Tommee Tippe, and Spectra Baby, among others.
Philippines Cancer Induced Bone Diseases Therapeutics Market
Philippines Cancer Induced Bone Disease Therapeutics Market valued at $3 Mn in 2022, projected to reach $5 Mn by 2030 with a 6.3% CAGR. The key drivers of this industry include increasing cancer incidence, expanding healthcare infrastructure, and government initiatives. The industry is primarily dominated by players such as Pharex Healthcare, Bayer, Merck, UniLab, TGP Group, Pascual Laboratories, Amgen, and Novartis among others.
Philippines Digital Biomarkers Market Analysis
Philippines Digital Biomarkers Market was valued at $6.38 Mn in 2023 and is predicted to grow at a CAGR of 22.8% from 2023 to 2030, to $26.87 Mn by 2030. The key drivers of this industry include the rising burden of chronic diseases, government initiatives, growing focus on preventative care, and the aging population. The industry is primarily dominated by ActiGraph LLC, AliveCor Inc., Koneksa, and Altoida Inc. among others.
Philippines Congestive Heart Failure Therapeutics Market Analysis
The Philippines Congestive Heart Failure Therapeutics Market is anticipated to experience a growth from $23 Mn in 2022 to $37 Mn by 2030, with a CAGR of 6.3% during the forecast period of 2022-2030. The key drivers of the market include the rising prevalence of CHF due to an aging population and increased risk factors, growing awareness and timely diagnosis leading to early intervention, and ongoing advancements in medications. The Philippines Congestive Heart Failure Therapeutics Market encompasses various key players across different therapeutic segments, including Novartis, AstraZeneca, Bayer, Abbott, Roche, Merck, Unilab, Metro Drug, Pharmaserv, Medichem, etc, among various others.
Philippines Exosome Research Market Analysis
The Philippines Exosome Research Market was valued at $0.4 Mn in 2023 and is projected to grow at a CAGR of 16.5% from 2023 to 2023, to $1.1 Mn by 2030. The key drivers of this industry are increasing prevalence and incidences of cancer and various auto-immune diseases, rising healthcare expenditure for better health services, growing R&D activities associated with exosome research, technological advancements in exosome isolation and analytical procedures, and increasing advanced applications of exosomes. The industry is primarily dominated by players such as Hologic Inc., Luminex Corporation, Thermo Fisher Scientific, Cell Guidance Systems LLC, and others.
Philippines Cardiac Resynchronization Therapy Market
Philippines Cardiac Resynchronization Therapy Market valued at $11 Mn in 2022, projected to reach $16 Mn by 2030 with a 5.5% CAGR. The notable increase in heart failure cases worldwide, propelled by aging demographics and lifestyle-associated cardiovascular ailments, stands as a pivotal factor fuelling the growth of the Cardiac Resynchronization Therapy (CRT) market. Presently, key players in this market encompass Abbott, Biotronik, Boston Scientific, Medtronic, St. Jude Medical, Sorin Group, Siemens Healthineers, Philips Healthcare, GE Healthcare, and Esaote.
Philippines Medication Access Programs Market Analysis
The Philippines Medication Access Programs Market was valued at $12.1 Mn in 2023 and is predicted to grow at a CAGR of 15.1% from 2023 to 2030, to $32.3 Mn by 2030. The key drivers of this industry include disease burden, government initiatives, and increasing healthcare awareness. The industry is primarily dominated by players such as Takeda Pharmaceuticals, Pfizer, Novartis, and Merck among others.
Philippines Physiotherapy Equipment Market Analysis
The Philippines Physiotherapy Equipment Market was valued at $45.98 Mn in 2023 and is predicted to grow at a CAGR of 7.7% from 2023 to 2030, to $77.28 Mn by 2030. The key drivers of this industry include the rising prevalence of chronic diseases, expanding geriatric population, and advancements in technology. The key players in the industry are BIODEX, BTL Industries, Prife International, and Biosyn Healthcare Systems, Inc. among others.
Philippines Cardiac Arrhythmia Therapeutics Market
Philippines Cardiac Arrhythmia Therapeutics Market valued at $16 Mn in 2022, projected to reach $26 Mn by 2030 with a 6.3% CAGR. The key drivers of this industry include rising incidence of cardiac arrhythmias, increased healthcare spending, and technological advances. The industry is primarily dominated by players such as Abbott, Philips Healthcare, Boston Scientific, United Laboratories, Siemens, and Zuellig among others.
Philippines Patient Adherence Programs Market Analysis
The Philippines Patient Adherence Programs Market was valued at $28.5 Mn in 2023 and is predicted to grow at a CAGR of 18.5% from 2023 to 2030, to $93.5 Mn by 2030. The key drivers of the market include increasing non-adherence, rising chronic conditions, and an aging population. The prominent players in the Philippines Patient Adherence Programs Market are Abbott Laboratories, Ajanta Pharma, Bauch Laboratories, EL Laboratories, Euro-Med Laboratories, and Pascual Laboratories, among others.